Bristol-Myers Squibb has expanded its access to clinical trial data with its new collaboration with Duke University through the Duke Clinical Research Institute (DCRI). Bristol-Myers Squibb will expand access to a broader set of clinical trial information and allow an independent scientific review through DCRI of requests from researchers who meet specific requirements. This collaboration is an initiative by Bristol-Myers Squibb to enhance its policies on research transparency and disclosure of clinical trial information.